Skip to main content

CAP TODAY/Genentech Webinar: Late breaking update on PD-L1 testing in TNBC

Thank you

This live web event has ended. Thank you for attending.

Description



Late breaking update on
PD-L1 testing in Triple-
Negative Breast Cancer


Why should you register now for this webinar?
Hear national thought leaders discuss updates on PD-L1 testing in
triple-negative breast cancer (TNBC)
Brought to you by: CAP TODAY
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Presenters: Hope S. Rugo, MD, and Gary Tozbikian, MD

What will this webinar empower you to do?

Comprehend the latest update on PD-L1 testing in TNBC
Gain insight into the optimal interchange between pathologists and oncologists
Understand the importance of PD-L1 testing in TNBC now and into the future
Ask questions of our distinguished presenters

CAP TODAY does not endorse any of the products or services named within.
The webinar is made possible with support from Genentech to CAP TODAY.

Contributors

  • Bob McGonnagle

    Publisher, CAP TODAY

  • Hope S. Rugo, MD, FASCO

    Professor of Medicine Director, Breast Oncology and Clinical Trials Education

  • Gary Tozbikian, MD

    Associate Professor
    Director, Division of Breast Pathology
    Department of Pathology
    Wexner Medical Center at The Ohio State University

November 20, 2019
Wed 9:00 AM CST

Duration 1H 0M

This live web event has ended.

For Technical Support
+1 (858) 201-4136